GlassScriptPhysician profile
Michelle L Schear
NPI 1639553498
$1,509.08
in general payments reported to CMS, 2019-2025
17 companies · $631 in 2025
The $631 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $429 · 2022: $256 · 2023: $92.84 · 2024: $100 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $234.90 | 2021-2025 | Watchman Flx |
| Insmed, INC. | $159.55 | 2025 | Arikayce |
| Edwards Lifesciences Corporation | $144.75 | 2022 | |
| Inspire Medical Systems, INC. | $136.99 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $124.73 | 2025 | |
| Abbott Laboratories | $111.42 | 2022 | |
| Alkermes, INC. | $102.96 | 2021 | |
| Neurelis, INC. | $100.46 | 2024 | Valtoco |
| Gilead Sciences, INC. | $96.20 | 2021 | |
| Atricure, INC. | $92.84 | 2023 | |
| Exact Sciences Corporation | $88.85 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $35.28 | 2021 | |
| Eisai INC. | $29.01 | 2021 | |
| Novo Nordisk INC | $13.92 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.12 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.67 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Schear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.